Kevin T. Larkin has been President, Chief Executive Officer and a member of the Company’s board of directors since May 2001. From July 1998 to April 2001, Mr. Larkin served as President and Chief Executive Officer of CardioVasc, Inc., a privately held developer and marketer of small-diameter vascular stent-grafts. From 1992 to 1997, Mr. Larkin served as Vice President of Sales and Marketing of Ventritex Inc., a publicly traded designer, developer, manufacturer and marketer of implantable defibrillators and related products for the treatment of ventricular tachycardia and ventricular fibrillation, which was acquired by St. Jude Medical in 1997. Prior to that, Mr. Larkin served in a variety of sales, marketing, and business development functions with Medtronic and Cordis Corporation (a Johnson & Johnson company).
Jeffrey L. Creech, Ph.D. has been Vice President of Regulatory, Clinical and Research Programs since July 2017 and served as Director since March 2009. Dr. Creech is responsible for clinical trial management, regulatory submissions and compliance, and reimbursement initiatives at the Company. Dr. Creech served primarily in management positions in Research and Regulatory with the Company from September 1998 to March 2009. During his time in Research, Dr. Creech co-authored more than 20 patents and managed independent research projects in wound healing, stroke treatment, and oncology. Dr. Creech received a Ph.D. in Chemical Engineering from the University of California, Berkeley, studying ocular surface fluid mechanics.
Edward M. Denton has been National Sales Manager since September 2018. From February 2000 to August 2018, Mr. Denton served in various sales and sales leadership roles for Medtronic, a developer and manufacturer of medical devices. Prior to that, Mr. Denton served in sales and sales leadership for Ventritex, Inc., a publicly traded designer, developer, manufacturer and marketer of implantable defibrillators and related products for treatment of ventricular arrhythmias, which was acquired by St. Jude Medical in 1997. Prior to that, Mr. Denton served in sales and sales leadership with Cordis Corporation as a developer, and manufacturer of coronary devices. Mr. Denton received a B.S. degree from the University of Georgia.
John S. Gilkerson has been Director of Manufacturing and Operations since November 2013 and served with the Company as Manager of Manufacturing and Operations since November 2000. From 1977 to 2000, Mr. Gilkerson served in a variety of positions, including Quality Assurance Operations Manager and Senior Manufacturing Engineer with the Cardiovascular Division of Baxter International, Inc. (and their acquired companies), a publicly traded developer, manufacturer, and marketer of healthcare products.
Jeffrey G. Kay has been Director of Quality Systems since August 1996, ensuring compliance with U.S. and European regulations. From October 1992 to July 1996, Mr. Kay served as the Quality Assurance Manager for Cordis Webster, now Biosense Webster. From May 1990 to October 1992, Mr. Kay was the Quality Assurance Manager for InterTherapy, a pioneer in the field of intravascular ultrasound catheter technology. Mr. Kay began his career in medical device quality systems in 1985 at the Paramax Division of Baxter International.
Stephen E. Myrick has been Vice President of Engineering since June 2018 and served as Director since January 2006. Mr. Myrick started with the Company as a Senior Project Engineer in October 1998 and has co-authored 23 issued U.S. patents related to superoxygenation technology. From January 1988 to September 1998, Mr. Myrick served as a Manager and Engineer for TRW, Inc., a publicly traded aerospace company later acquired by Northrop Grumman Corporation. Mr. Myrick received a B.S. degree in Mechanical Engineering from the University of California, Irvine.
Denise A. Strogatz has been Director of Finance since August 1999 and served as the Company’s Controller from February 1998 to August 1999. From June of 1993 to present, Ms. Strogatz has consulted with many medical device companies and served as an Accounting Manager from June 1993 to October 1995 for an incontinence device developer and manufacturer which was acquired by Boston Scientific Corporation in 1995. Ms. Strogatz received her AA degree in Accounting from Saddleback College.